BKD vs CHE Stock Comparison

Brookdale Senior Living and Chemed Prices as of Nov 13, 2026 Peers: Industry group
CHE Chemed Corp
$548.44 +6.9% 1M +23.0% 1Y
Market cap
$7.16B
P/E
25.4x
Revenue (TTM)
$2.66B
Div. yield
0.00%
Home Health and Senior Care Healthcare
8 wins

Head to Head

9 decided of 12

Chemed leads on 8 of the 12 questions below (Chemed 8, Brookdale Senior Living 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBKDCHELeader
Larger companyMarket capitalisation $2.13B $7.16B CHE
Cheaper on earningsLower P/E, profitable companies only -56.9x 25.4x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 20.4x –
Faster revenue growthRevenue growth, trailing twelve months -8.4% +5.2% CHE
More profitableNet margin, trailing twelve months -1.3% 10.6% CHE
Better return on capitalReturn on invested capital 4.7% 26.5% CHE
Less leveragedLower net debt / EBITDA 7.8x 0.4x CHE
Higher dividend yieldTrailing dividend yield 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -11.2% +23.0% CHE
Better 5-year returnAnnualised price return, 5 years +5.1%/yr +1.8%/yr BKD
Less volatileAnnualised volatility, 1 year 43.7% 29.3% CHE
Higher overall scoreMean of the five percentile scores vs peers 45/100 59/100 CHE

Percentile Scorecard

BKDCHE

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBKDCHE
Valuation 56 #44 of 99 45 #55 of 99
Growth 57 #39 of 89 18 #73 of 89
Profitability 54 #43 of 92 93 #7 of 92
Financial Health 14 #89 of 103 68 #34 of 103
Shareholder Returns – 69 #20 of 63
Overall 45 59
  • BKD ranked among 103 companies in Healthcare Providers
  • CHE ranked among 103 companies in Healthcare Providers

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBKDCHESPY
1 month -9.2%+6.9% -2.0%
3 months -27.4%+2.9% -2.8%
6 months -29.6%+26.2% +2.0%
Year to date -14.9%+28.2% +10.6%
1 year -11.2%+23.0% +12.2%
3 years +108.6%-6.6% +68.1%
3 years, per year +27.8%-2.2% +18.9%
5 years +28.0%+9.3% +61.4%
5 years, per year +5.1%+1.8% +10.1%
10 years -23.8%+272.8% +248.5%
10 years, per year -2.7%+14.1% +13.3%

Risk

MeasureBKDCHESPY
Volatility, 1Y 43.7%29.3% 13.6%
Downside volatility, 1Y 47.3%32.4% 13.9%
Beta vs S&P 500, 1Y 0.330.09 1.00
Return / volatility, 1Y -0.260.78 0.90
Max drawdown, 5Y -68.6%-43.4% -25.4%
From 52-week high -45.3%-0.7% -3.2%
52-week high $16.77$552.43 $779.14
52-week low $8.97$368.59 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBKDCHE
P/E now vs peer median -58.6xmedian 22.4x 25.4xmedian 22.4x
P/S now vs peer median 0.7xmedian 1.3x 2.7xmedian 1.3x
EV/EBITDA now vs peer median 12.1xmedian 14.2x 16.7xmedian 14.2x
P/FCF now vs peer median -12.9xmedian 19.0x 24.2xmedian 19.0x
P/B now vs peer median -55.9xmedian 2.6x 8.3xmedian 2.6x
PEG now vs peer median -1.72median 0.84 2.50median 0.84

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBKDCHE
Revenue $2.95B $2.66B
Gross profit $2.86B $892.52M
Operating income $200.90M $370.86M
Net income -$37.53M $282.40M
Free cash flow -$169.49M $295.45M
EPS (diluted) $-0.16 $21.50
Cash & equivalents $323.37M $48.43M
Total debt $4.35B $236.00M
Shares (diluted) 239.14M 13.14M
Enterprise value $845.57M $6.98B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBKDCHE
P/E -58.6x 25.4x
P/FCF -12.9x 24.2x
P/Operating cash flow 9.4x 19.7x
P/S 0.7x 2.7x
P/B -55.9x 8.3x
P/Tangible book -55.9x 9.1x
EV/EBITDA 12.1x 16.7x
EV/EBIT 30.8x 19.8x
EV/Revenue 2.1x 2.8x
EV/FCF -36.6x 24.8x
EV/Operating cash flow 26.7x 20.2x
PEG (3Y EPS CAGR) -1.72 2.50

Growth

14 metrics
MetricBKDCHE
Revenue growth (1Y) -8.4% 5.2%
Revenue CAGR (3Y) -0.1% 6.1%
Gross profit growth (1Y) -7.2% 6.9%
Gross profit CAGR (3Y) 1.0% 5.1%
Operating income growth (1Y) 1,848% 5.5%
Operating income CAGR (3Y) 43.3% 6.1%
Net income growth (1Y) 87.8% 1.3%
Net income CAGR (3Y) 32.8% 4.9%
EPS growth (1Y) 87.9% 11.1%
EPS CAGR (3Y) 34.1% 10.1%
Operating cash flow growth (1Y) 1.6% -13.5%
Operating cash flow CAGR (3Y) 39.8% 4.1%
Free cash flow growth (1Y) 55.3% -18.0%
Free cash flow CAGR (3Y) -7.5% 4.5%

Profitability

14 metrics
MetricBKDCHE
Gross margin 97.0% 33.5%
EBITDA margin 17.3% 16.5%
Operating margin 6.8% 13.9%
Pretax margin -1.2% 14.4%
Net margin -1.3% 10.6%
FCF margin -5.7% 11.1%
Operating cash flow margin 7.9% 13.6%
Return on equity – 33.4%
Return on assets -0.6% 17.1%
Return on invested capital 4.7% 26.5%
Return on capital employed 3.7% 28.1%
Asset turnover 0.5x 1.6x
Cash conversion (OCF / net income) -6.2x 1.3x
Stock comp / revenue 0.5% 1.2%

Financial Health

11 metrics
MetricBKDCHE
Debt / assets 73.4% 13.7%
Debt / equity -111.0x 0.3x
Net debt / EBITDA 7.8x 0.4x
Debt / FCF -25.7x 0.8x
Liabilities / assets 100.7% 49.9%
Equity / assets -0.7% 50.1%
Interest coverage 0.9x 75.4x
Current ratio 1.1x 1.1x
Quick ratio 0.8x 0.9x
Cash ratio 0.7x 0.1x
Altman Z-score -0.18 9.84

Shareholder Returns

7 metrics
MetricBKDCHE
Dividend yield – 0.5%
Net buyback yield – 6.9%
Shareholder yield 0.0% 7.4%
Payout ratio (earnings) – 11.9%
Payout ratio (FCF) – 11.4%
Dividend growth (1Y) – 9.9%
Dividend CAGR (3Y) – 13.5%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBKDCHE
Forward P/E – 20.4xFY2026
EPS, next fiscal year $-0.03FY2026 $26.82FY2026
EPS growth, next FY – +24.5%FY2026
EPS growth, the year after – +8.1%
Revenue, next fiscal year $2.78BFY2026 $2.67BFY2026
Revenue growth, next FY -12.9%FY2026 +5.5%FY2026
Revenue growth, the year after +3.0% +15.5%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBKDCHE
Held by institutions 100.0% 100.0%
Institutions holding 293 528
Change in shares held, QoQ +5.6% +2.8%
Institutions buying 165 276
Institutions selling 92 187
Buyers to sellers 1.79 1.48

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BKDCHE
BKD 1.00 0.16
CHE 0.16 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BKD and CHE?

Chemed (CHE) is the largest by market capitalisation: Brookdale Senior Living (BKD) $2.13B, Chemed (CHE) $7.16B.

Which company is growing faster?

Chemed (CHE) grew revenue fastest over the trailing twelve months: Brookdale Senior Living (BKD) -8.4%, Chemed (CHE) +5.2%.

Which company is more profitable?

Chemed (CHE) has the highest net margin (Brookdale Senior Living (BKD) -1.3%, Chemed (CHE) 10.6%). On return on invested capital, Chemed (CHE) leads (Brookdale Senior Living (BKD) 4.7%, Chemed (CHE) 26.5%).

Which stock has performed better?

Over the past year Chemed (CHE) returned the most: Brookdale Senior Living (BKD) -11.2%, Chemed (CHE) +23.0%. Over five years, Brookdale Senior Living (BKD) compounded fastest (Brookdale Senior Living (BKD) +5.1%/yr, Chemed (CHE) +1.8%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Brookdale Senior Living (BKD) 0.00%, Chemed (CHE) 0.00%. Brookdale Senior Living (BKD) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Chemed (CHE) has been the steadiest (Brookdale Senior Living (BKD) 43.7%, Chemed (CHE) 29.3%). Volatility measures how widely the price swings, not the risk of the business.

Do BKD and CHE move together?

Their daily returns over the past year have a correlation of 0.16, a weak relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, BKD and CHE?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Chemed (CHE) leads on 8. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.